WAEPS - Monthly Scientific Meetings
Presented jointly with the Univ. of Washington Department of Ophthalmology
Join your colleagues for a monthly learning session presented by top experts in a variety of ophthalmology sub-specialties. Program is held at the training auditorium at Harborview Medical Center in Seattle from 6:30 p.m. to 8:30 p.m. In addition, the series is available to members throughout the state via webinar. Be sure to register online on this page of the WAEPS website and you will automatically receive an email with login instructions. Or contact the WAEPS office: waeps@waeps.org
Schedule:
Check in and light refreshments: 6:00 p.m.
Presentations at 6:30 and 7:30 p.m.
WAEPS members may self-register online for each month’s program using the link on this page. Your automatic confirmation email will contain the webinar login information for that month’s session. If you need assistance with registration or do not receive your confirmation, please contact the WAEPS office no later than 3 p.m. on the day of the session you plan to participate in. Contact [email protected] or call 206-956-3650.
Credit for the series is an exclusive WAEPS member benefit and free of charge. Members in good standing of neighboring states' ophthalmology societies may also be eligible. Check with the WAEPS office for details.
Note that to earn CME credit you must track your attendance and submit a credit claim form at the end of the series and you must sign in to each session you attend. More details will be made available when you register. Click here to download the form for the 2018-19 series.
If you participated in a previous year's series and have a question about your CME credit, please contact Kimberly Conn, WAEPS Executive Director: [email protected] or phone: 206-956-3652.
(Requires Member Login)
2018-19 Monthly Scientific Meeting Series:
February 13, 2019
M. Tariq Bhatti, MD
Mayo Clinic
Disclosures: Dr. Bhatti has disclosed the following relationships with ACCME-defined commercial interests: consulting/speaking fees – Receptos. His presentation will be evidence based and free of bias.
Lecture 1: "Giant Cell Arteritis: A neuro-ophthalmologist’s perspective"
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- Describe the clinical manifestations of giant cell arteritis
- Utilize temporal artery biopsy in the diagnosis of giant cell arteritis.
- Apply research regarding effectiveness of immunosuppressant drugs (e.g.) tocilizumab, in the management of giant cell arteritis.
Lecture 2: "The mighty mito: the story of gene therapy for Leber hereditary optic neuropathy"
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- Describe to patients the genetic transmission of mitochondrial disease.
- Follow the developments of gene therapies on the horizon for LHON as the research advances.
Future programs:
March 13, 2019
William Harbour, MD
Professor & Vice Chairman; Dr. Mark J. Daily Endowed Chair; Director, Ocular Oncology Service
Bascom Palmer Eye Institute
Disclosures: Dr. Harbour has disclosed the following relationships with ACCME-defined commercial interests: royalty payments, intellectual property rights and consulting/speaking fees from Castle Biosciences. His presentation will be evidence based and free of bias.
Lecture 1: Clinical update on retinoblastoma
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- Identify keys to diagnosing retinoblastoma and simulating lesions
- Discuss current treatment options for retinoblastoma with patients and colleagues
- Properly utilize genetic testing and new treatment options in retinoblastoma cases.
Lecture 2: Clinical update on intraocular lymphoma
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- List at least two forms of intraocular lymphoma
- Determine which of the various options for diagnosing these cancers is most appropriate for their patients.
- Recognize systemic implications of intraocular lymphoma.
April 24, 2018
Anthony J. Aldave, MD
Professor of Ophthalmology; Walton Li Chair in Cornea and Uveitis
Chief, Cornea and Uveitis Division
Director, Cornea and Refractice Surgery Fellowship
The Jules Stein Eye Institute, UCLA, Los Angeles, CA
Disclosures: Dr. Aldave has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: Customized corneal transplantation: a revolution in evolution
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- Describe the criteria that should be considered when deciding whether to perform penetrating keratoplasty (PK) versus deep anterior lamellar keratoplasty (DALK) for corneal ectasia and corneal stromal scarring.
- Assess the pros and cons of Descemet membrane endothelial keratoplasty (DMEK) over Descemet stripping endothelial keratoplasty (DSEK).
- List some of the outcomes of repeat penetrating keratoplasty versus Boston type I keratoprosthesis implantation for corneal transplant failure
Lecture 2: Cataract surgery in patients with corneal disease: pearls and pitfalls
Learning objectives: after participating in this activity attendees will be able to apply new approaches to:
- Describe the indications for treating epithelial basement membrane corneal dystrophy.
- Apply best practice criteria in deciding when to perform endothelial keratoplasty in conjunction with cataract surgery in patients with Fuchs endothelial corneal dystrophy.
- Generate strategies to minimize the risk of endothelial decompensation when performing cataract extraction in the patient with Fuchs endothelial corneal dystrophy.
May 15, 2019
Sunir Garg, MD, FACS
Professor of Ophthalmology; Co-director Retina Research Unit
The Retina Service of Wills Eye Hospital
Editor in Chief, Retina Times, Thomas Jefferson University
Disclosures: Dr. Garg has disclosed the following relationships with ACCME-defined commercial interests: consulting/speaking fees – Bausch & Lomb, Deciphera, Santen and grant/research support – Aerpio, Allergan, Eyegate. His presentation will be evidence based and free of bias.
Lecture 1: What Intravitreal Injections Have Taught Us About Endophthalmitis
Objectives – after participating in this activity, the attendees should be able to:
- Identify risk factors for the development of endophthalmitis
- Apply best practice strategies to prevent development of endophthalmitis in patients
Lecture 2: Management of Retained Lens Material
Objectives – after participating in this activity, the attendees should be able to:
- Describe predisposing risk factors for the development of retained lens material
- Apply the most current intrasegment strategies and vitreoretinal techniques to manage retained lens material.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Washington School of Medicine and Washington Academy of Eye Physicians and Surgeons. The University of Washington School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
The University of Washington School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 2.0 credits)
Planning Committee Disclosures:
Committee member Dr. Aaron Lee, MD, PhD, has no relevant commercial interests to disclose.
Committee member Dr. Russell Van Gelder has no relevant commercial interests to disclose.
To view an archive of past Monthly WAEPS Scientific Meetings, please click here. Please note, you must be logged in to access the archive page.
|
